Menu
1-702-720-6310 info@microcapspecualtors.com

Undervalued Cannabis and Biotech Firms

  • September 10, 2018

The most valuable sector of the Cannabis Industry may just be the extract of Cannabidiol (CBD), which has transformed into a wide variety of products ranging from health supplements to pet products. CBD based products have generated billions in revenue…

Read More

Cannabis and Biotech Firms Uptrending

  • September 10, 2018

A fascinating biotech firm DCTH (Delcath Systems, Inc.), has an intriguing treatment for liver cancer.  The company has initiated a global Phase 3 clinical trial for patients with intrahepatic cholangiocarcinoma (ICC), using its drug product Melphalan/HDS.  DCTH reported that the…

Read More

5 Biotech Stocks to Watch

  • September 6, 2018

Biotech stocks have been making investors major profits for years. Recently, the stem cell market has started to heat up again.   One stock leading that push has been BioRestorative Therapies, Inc. (BRTX).  The stock has been receiving increased attention…

Read More

Cannabis and Biotech Firms Set to Explode

  • September 4, 2018

We have discovered an incredibly unique stem cell firm, BRTX (BioRestorative Therapies, Inc.). BRTX is on the cusp of receiving major attention from the street.  As BRTX prepares for its Phase 2 clinical trial using BRTX-100 to treat chronic lumbar…

Read More

Cannabis and Biotech Stocks on High Alert

With Cannabis and biotechnology companies currently being the talk of the town, we believe we have located some very interesting firms that present lasting opportunities.  Just a couple weeks ago now Cannabis went mainstream with STZ investing $4 Billion into…

Read More

5 Marijuana Stocks Ready To Explode

The global coffee market, which is one of the most valuable commodities globally is valued at about $80 billion per year. Nonetheless, the global cannabis market is valued at about $142 billion. Cannabis is considered the largest cash crop in…

Read More

Cannabis Companies Set to Explode, at any Moment

On June 25, the FDA approved London-based GW Pharma’s Epidiolex, a drug containing CBD as its active ingredient, to treat two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients 2 years old and older.  This…

Read More

Cannabis Mergers, Acquisitions, and IPOs

The Cannabis industry remains volatile, and inconsistent regulations can make expansion difficult. Nonetheless, in 2018 the cannabis industry in states like California are still finding their footing on many fronts with both a regulatory framework and banking solution being very…

Read More

Will There be Another MJ Gold Rush this Fall?

Microcapspeculators.com is an informational website that is highly interested in exploring development stage companies, enroute to finding companies with the best potential. It seems that every fall there is a massive rush into Marijuana related companies.  This could be due…

Read More
Search